estrone has been researched along with sirolimus in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Alvord, WG; Baba, M; Bernardo, M; Choyke, P; Furihata, M; Haines, DC; Hong, SB; Igarashi, P; Ileva, L; Leighty, R; Linehan, WM; Patel, V; Schmidt, LS; Southon, E; Tessarollo, L; Warren, MB; Yao, M; Zbar, B | 1 |
Adelstein, RS; Baba, M; Haines, DC; Hasumi, H; Hasumi, Y; Huang, Y; Lang, M; Marston Linehan, W; Nagashima, K; Oh, HB; Reindorf, R; Sadoshima, J; Schmidt, LS; Schneider, MD; Sciarretta, S | 1 |
1 review(s) available for estrone and sirolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for estrone and sirolimus
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.
Topics: Animals; Antibiotics, Antineoplastic; Blotting, Southern; Cell Proliferation; Disease Models, Animal; Estrone; Fluorescent Antibody Technique; Gene Silencing; Genotype; Germ-Line Mutation; Immunoblotting; Immunohistochemistry; Kaplan-Meier Estimate; Kidney; Kidney Neoplasms; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Polycystic Kidney Diseases; Protein Kinases; Proto-Oncogene Proteins; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sirolimus; Syndrome; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins | 2008 |
Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cell Line; Disease Models, Animal; Enzyme Activation; Estrone; Gene Silencing; Heart Failure; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Transgenic; Mitochondrial Turnover; Multiprotein Complexes; Organ Size; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Ventricular Function | 2014 |